In addition to the investigation into tegaserod's targeting of YTHDF1 for AML treatment, recent research has unveiled Salvianolic acid C (SAC), a principal constituent of the traditional Chinese medicine Danshen, as a promising YTHDF1 inhibitor. The gene discussed is YTHDF1; the disease is acute myeloid leukemia.